These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18669654)

  • 1. GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein.
    Scherzer CR; Grass JA; Liao Z; Pepivani I; Zheng B; Eklund AC; Ney PA; Ng J; McGoldrick M; Mollenhauer B; Bresnick EH; Schlossmacher MG
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10907-12. PubMed ID: 18669654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease.
    Matsumoto L; Takuma H; Tamaoka A; Kurisaki H; Date H; Tsuji S; Iwata A
    PLoS One; 2010 Nov; 5(11):e15522. PubMed ID: 21124796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs in Parkinson's disease: Regulating SNCA and alpha-synuclein aggregation.
    Thangavelu L; Moglad E; Afzal M; Almalki WH; Malathi H; Bansal P; Rani B; Walia C; Sivaprasad GV; Rajput P; Imran M
    Pathol Res Pract; 2024 Sep; 261():155511. PubMed ID: 39094523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.
    Jowaed A; Schmitt I; Kaut O; Wüllner U
    J Neurosci; 2010 May; 30(18):6355-9. PubMed ID: 20445061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the α-synuclein gene in human brain tissue.
    Brenner S; Wersinger C; Gasser T
    Neurosci Lett; 2015 Jul; 599():140-5. PubMed ID: 26002080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson's Disease.
    Liscovitch N; French L
    PLoS One; 2014; 9(12):e115029. PubMed ID: 25493648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 11. Toward deciphering the mechanistic role of variations in the Rep1 repeat site in the transcription regulation of SNCA gene.
    Afek A; Tagliafierro L; Glenn OC; Lukatsky DB; Gordan R; Chiba-Falek O
    Neurogenetics; 2018 Aug; 19(3):135-144. PubMed ID: 29730780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
    Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
    Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation of intron1 of α-synuclein gene does not correlate with Parkinson's disease.
    Guhathakurta S; Evangelista BA; Ghosh S; Basu S; Kim YS
    Mol Brain; 2017 Feb; 10(1):6. PubMed ID: 28173842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.
    Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O
    Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.
    Westerlund M; Belin AC; Anvret A; Håkansson A; Nissbrandt H; Lind C; Sydow O; Olson L; Galter D
    FASEB J; 2008 Oct; 22(10):3509-14. PubMed ID: 18606870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.
    Uehara T; Choong CJ; Nakamori M; Hayakawa H; Nishiyama K; Kasahara Y; Baba K; Nagata T; Yokota T; Tsuda H; Obika S; Mochizuki H
    Sci Rep; 2019 May; 9(1):7567. PubMed ID: 31110191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
    Häbig K; Walter M; Stappert H; Riess O; Bonin M
    Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Parkinson's Disease-Associated Gene Alpha-Synuclein is Regulated by the Neuronal Cell Fate Determinant TRIM32.
    Pavlou MAS; Colombo N; Fuertes-Alvarez S; Nicklas S; Cano LG; Marín MC; Goncalves J; Schwamborn JC
    Mol Neurobiol; 2017 Aug; 54(6):4257-4270. PubMed ID: 27339877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.